Search

Huiqiang Qiang Zhou

from Chapel Hill, NC
Age ~62
Get Report
Also known as:
Huiqiang Q Zhou, Hui Qiang Zhou, Hui Q Zhou, Wei Hua Zhou, Huquan Zhou, Weihua Zhou, Qiang Zhou Huiqiang, Qiang Zhou Hui, Huiqiang Qiang Zhouhui, Wei Zhao
Phone and address:
103 Old Markham Pl, Chapel Hill, NC 27514
(919) 401-9139
Related to:
Xuxiang Zhang, 53Susan N Wong, 48Pei Z Xu, 88Zhourong Cao, 82Wen Chen, 48
Connected to:
Aihua Zhou, 47Aishi Zhou, 74Angela Zhou, 56Anqi Zhou, 57Anqiang Zhou, 80Bonnie Zhou, 65Boyu Zhou, 34Calvin J Zhou, 40Carolyn L Zhou, 27Cecilia Zhou, 55

Huiqiang Zhou Phones & Addresses

  • 103 Old Markham Pl, Chapel Hill, NC 27514 (919) 401-9139
  • 102 Pinegate Cir, Chapel Hill, NC 27514 (919) 401-9139
  • 4411 Emerald Forest Dr, Durham, NC 27713 (919) 484-0026
  • 415 78Th St, Omaha, NE 68114 (402) 343-0743
  • Minneapolis, MN
  • 103 Old Markham Pl, Chapel Hill, NC 27514 (919) 278-8297

Work

Company: Glaxosmithkline Position: Investigator

Education

School / High School: Fudan University

Skills

Pharmaceutical Industry

Emails

d***[email protected]

Industries

Pharmaceuticals

Resumes

Resumes

Huiqiang Zhou Photo 1

Retiree From Glaxosmithkline

View page
Location:
Durham, NC
Industry:
Pharmaceuticals
Work:
GlaxoSmithKline
Investigator
Education:
Fudan University
Skills:
Pharmaceutical Industry

Publications

Us Patents

Alpha-Ketoamide Derivatives As Cathepsin K Inhibitors

View page
US Patent:
20050107616, May 19, 2005
Filed:
Jul 23, 2002
Appl. No.:
10/485656
Inventors:
David Gene Barrett - Hauctecht-Ulzburg, DE
David Deaton - Durham NC, US
Robert Mcfadyen - Durham NC, US
Aaron Miller - Durham NC, US
John Ray - Durham NC, US
Francis Tavares - Durham NC, US
Huiqiang Zhou - Durham NC, US
International Classification:
C07D213/55
C07D207/46
US Classification:
546335000, 548571000, 558234000, 560033000
Abstract:
Biaryl ketoamide derivatives, which are useful as cathepsin K inhibitors are described herein. The described invention also includes methods of making such biaryl ketoamide derivatives as well as methods of using the same in the treatment of disorders, including osteoporosis, associated with enhanced bone turnover which can ultimately lead to fracture.

Pyradazine Compounds As Gsk-3 Inhibitors

View page
US Patent:
20060069097, Mar 30, 2006
Filed:
Oct 14, 2003
Appl. No.:
10/530985
Inventors:
Scott Dickerson - Durham NC, US
Francis Tavares - Durham NC, US
Huiqiang Zhou - Durham NC, US
International Classification:
A61K 31/502
C07D 487/04
US Classification:
514248000, 544236000
Abstract:
The present invention relates generally to inhibitors of the kinases, such as GSK3, and more particularly to fused pyradazine compounds and methods of their use.

Heterocyclic Mchr1 Antagoists

View page
US Patent:
20060194871, Aug 31, 2006
Filed:
Apr 6, 2004
Appl. No.:
10/552232
Inventors:
Kevin Barvian - Durham NC, US
Andrew Carpenter - Durham NC, US
Joel Cooper - Durham NC, US
Paul Feldman - Durham NC, US
Dulce Garrido - Durham NC, US
Yu Guo - Durham NC, US
Anthony Handlon - Durham NC, US
Donald Hertzog - Durham NC, US
Clifton Hyman - Durham NC, US
Andrew Peat - Durham NC, US
Gregory Peckham - Durham NC, US
Jason Speake - Durham NC, US
William Swain - Durham NC, US
Francis Tavares - Durham NC, US
Huiqiang Zhou - Durham NC, US
International Classification:
C07D 311/80
A61K 31/353
US Classification:
514455000, 549387000, 549390000
Abstract:
This invention relates to novel heterocycles which are antagonists at the melanin-concentrating hormone receptor 1 (MCHR1), also referred to as 11 CBy, to pharmaceutical compositions containing them, to processes for their preparation, and to their use in medicines. Compounds of the invention have the formula:
Control profile
Huiqiang Qiang Zhou from Chapel Hill, NC, age ~62 Get Report